Lite Strategy, Inc. — Director's Dealing 2023

Mar 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2023-02-28

Reporting Person: Baltic Charles V. III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-28	Common Stock	P	81500	$0.225	Acquired	105750	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5350	Indirect